MEDCL — Medincell SA Cashflow Statement
0.000.00%
Last trade - 00:00- €941.31m
- €913.90m
- €19.52m
Annual cashflow statement for Medincell SA, fiscal year end - March 31st, EUR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -24.8 | -32 | -25 | -18.4 | -31.3 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 4.29 | 12.4 | 8.31 | 11.5 | 14.7 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2.37 | -3.04 | 3.09 | 24.4 | -9.79 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -21.4 | -21 | -11.9 | 19.5 | -24.6 |
| Capital Expenditures | -1.97 | -1.03 | -1.19 | -1.66 | -2.04 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 1.66 | 2.33 | 0.578 | -11.6 | -8.46 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.316 | 1.3 | -0.613 | -13.2 | -10.5 |
| Financing Cash Flow Items | -1.13 | -4.46 | -2.15 | -1.7 | -1.9 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.8 | 1.56 | 25.5 | 33.3 | 38.8 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -22.5 | -18.1 | 13 | 39.6 | 3.75 |